Abstract
The concept of receptor-mediated metabolism of lipoproteins emerged 17 years ago from studies on human skin fibroblasts grown in culture1. These experiments were designed to elucidate the normal function of low density lipoprotein (LDL), about which little was known at that time. Biochemical studies showed that a specific cell surface receptor, the LDL receptor, mediates the binding, uptake and degradation of LDL, thus supplying almost all cells in the body with cholesterol. Detailed insight into the molecular mechanisms underlying this complex process was obtained from studies with fibroblasts derived from patients with the phenotype of homozygous familial hypercholesterolemia (FH). As in many other biological systems, the expression of a disease state in a defined cellular system was essential to the discovery of the causal factor: FH is now one of the best characterized genetic diseases at the molecular level. As will be outlined below, several groups of mutations occur naturally in the structural gene for the LDL receptor which disrupt its normal function and lead to severe hypercholesterolemia, myocardial infarctions and premature atherosclerosis. Thus, the important role of lipoprotein receptors in normal physiology is underscored by the dramatic consequences of their functional absence.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Brown, M.S. and Goldstein, J.L. 1974. Familial hypercholesterolemia-defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity. Proc. Natl. Acad. Sci. 71: 788.
Goldstein, J.L. and Brown, M.S. 1990. Regulation of the mevalonate pathway. Nature 343: 425.
Goldstein, J.L., Dana, S.E. and Brown, M.S. 1974. Esterification of low density lipoprotein cholesterol in human fibroblasts and its absence in homozygous familial hypercholesterolemia. Proc. Natl. Acad. Sci. USA 71: 4288.
Brown, M.S. and Goldstein, J.L. 1975. Regulation of activity of low density lipoprotein receptor in human fibroblasts. Cell 6: 307.
Brown, M.S. and Goldstein, J.L. 1976. Receptor-mediated control of cholesterol metabolism. Science 191: 150.
Goldstein, J.L. and Brown, M.S. 1976. LDL pathway in human fibroblasts. Receptor-mediated mechanisms for regulation of cholesterol metabolism. Curr. Topics Cell Reg. 11: 147.
Goldstein, J.L. and Brown, M.S. 1977. Low density lipoprotein pathway and its relation to atherosclerosis. Ann. Rev. Biochem. 46: 897.
Goldstein, J.L. and Brown, M.S. 1974. Binding and degradation of low-density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia. J. Biol. Chem. 249: 5153.
Fredrickson, D.S., Goldstein, J.L. and Brown, M.S. 1978. The familial hypercholesterolemias. In: The Metabolic Basis of Inherited Disease. Wyngaarden, J.B. and Fredrickson, D.S. (eds), McGraw-Hill, New York.
Goldstein, J.L. and Brown, M.S. 1978. Hypercholesterolemia. Pathogenesis of a receptor disease. John Hopkins Med. 143: 8.
Khachadurian, A.K. 1964. Inheritance of essential familial hypercholesterolemia. Am. J. Med. 37: 402.
Goldstein, J.L., Dana, S.E., Brunschede, G.Y. and Brown, M.S. 1975. Genetic heterogeneity in familial hypercholesterolemia. Evidence for 2 different mutations affecting function of low density lipoprotein receptor. Proc. Natl. Acad. Sci. USA 72: 1092.
Tolleshaug, H., Goldstein, J.L., Schneider, W.J. and Brown, M.S. 1982 Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia. Cell 30: 715.
Tolleshaug, H., Hobgood, K.K., Brown, M.S. and Goldstein, J.L. 1983. The LDL receptor locus in familial hypercholesterolemia. Multiple mutations disrupt transport and processing of membrane receptor. Cell 32: 941.
Goldstein, J.L. and Brown, M.S. 1983. Familial hypercholesterolemia. In: The Metabolic Basis of Inherited Disease. Stanbury, J.B., Wyngaardon, J.B., Fredrickson, D.S., et al. (eds), McGraw-Hill, New York.
Slack, J. and Nevin, N.C. 1968. Hyperlipidemic xanthomatosis. I. Increased risk of death from ischemic heart disease in first degree relatives of 53 patients with essential hyperlipidemia and xanthomatosis. J. Med. Genet. 5: 4.
Stone, N.J., Levy, R.I., Fredrickson, D.S. and Verber, J. 1974. Coronary artery disease in 116 kindred with familial type II hyperlipoproteinemia. Circulation 49: 476.
Yamamoto, T., Davis, C.G., Brown, M.S., Schneider, W.J., Casey, M.L., Goldstein, J.L. and Russell, D.W. 1984. The human LDL receptor. A cysteine-rich protein with multiple ALU sequences in its messenger RNA. Cell 39: 27.
Russell, D.W., Schneider, W.J., Yamamoto, T., Luskey, K.L., Brown, M.S. and Goldstein, J.L. 1984. Domain map of the LDL receptor. Sequence homology with the epidermal growth factor precursor. Cell 37: 577.
Sudhof, T.C., Goldstein, J.L., Brown, M.S. and Russell, D.W. 1985. Cassette of 8 exons shared by genes for LDL receptor and EGF precursor. Science 228: 815.
Innerarity, T.L., Weisgraber, K.H., Arnold, K.S., Rail, S.C. Jr. and Mahley, R.W. 1984. Normalization of receptor binding of apolipoprotein E2. Evidence for modulation of the binding site conformation. J. Biol. Chem. 259: 7261.
Knott, T.J., Rall, S.C. Jr., Innerarity, T.L., Jacobson, S.F., Urdena, M.S., Levy-Wilson, B., Powell, L.M., Pease, R.J., Eddy, R., Nakai, H., Byers, M., Priestly, L.M., Robertson, E., Rall, L.B., Betsholtz, C., Shows, T.B., Mahley, R.W. and Scott, J. 1985. Human apolipoprotein B. Structure of carboxyl terminal domains, sites of gene expression, and chromosomal location. Science 230: 37.
Goldstein, J.L., Brown, M.S., Anderson, R.G.W., Russell, D.W. and Schneider, W.J. 1985. Receptor-mediated endocytosis. Concepts emerging from the LDL receptor system. Ann. Rev. Cell Biol. 1: 1.
Mahley, R.W. and Innerarity, T.L. 1983. Lipoprotein receptors and cholesterol homeostasis. Biochim. Biohvs. Acta 737: 197.
Innerarity, T.L. and Mahley, R.W. 1978. Enhanced binding by cultured human fibroblasts of Apo-E containing lipoproteins as compared with low density lipoproteins. Biochemistry 7: 1440.
Pitas, R.E., Innerarity, T.L. and Mahley, R.W. 1980. Cell surface receptor binding of phospholipid-protein complexes containing different ratios of receptor-active and receptor-inactive E apolipoprotein. J. Biol. Chem. 255: 5454.
Basu, S.K., Goldstein, J.L., Anderson, R.G.W. and Brown, M.S. 1976. Degradation of cationized low density lipoprotein and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc. Natl. Acad. Sci. USA 73: 3178.
Schneider, W.J., Beisiegel, U., Goldstein, J.L. and Brown, M.S. 1982. Purification of the low density lipoprotein receptor. An acidic glycoprotein in 164,000 molecular weight. J. Biol. Chem. 257: 2664.
Scott, J., Urdea, M., Quiroga, M., Sanchez-Pescador, R., Fong, N., Selby, M., Rutter, W.J. and Bell G.I. 1983. Structure of a mouse submaxillary messenger RNA encoding epidermal growth factor and seven related proteins. Science 221: 236.
Gray, A., Dull, T.J. and Ullrich, A. 1983. Nucleotide sequence of epidermal growth factor cDNA predicts a 128,000 molecular weight protein precursor. Nature 303: 722.
Doolittle, R.F., Feng, D.-F. and Johnston, M.S. 1984. Computer-based characterization of epidermal growth factor precursor. Nature 307: 558.
Cummings, R.D., Kornfeld, S., Schneider, W.J., Hobgood, K.K., Tolleshaug, H., Brown, M.S. and Goldstein, J.L. 1983. Biosynthesis of N-linked and O-linked oligosaccharides of the low density lipoprotein receptor. J. Biol. Chem. 258: 15261.
Davis, C.G., Elhammer, A., Russell, D.W., Schneider, W.J., Kornfeld, S., Brown, M.S. and Goldstein, J.L. 1986. Deletion of clustered O-linked carbohydrates does not impair function of low density lipoprotein receptor in transfected fibroblasts. J. Biol. Chem. 261: 2828.
Beisiegel, U., Schneider, W.J., Goldstein J.L., Anderson, R.G.W. and Brown, M.S. 1981. Monoclonal antibodies to the low density lipoprotein receptor as probes for the study of receptor mediated endocytosis and the genetics of familial hypercholesterolemia. J. Biol. Chem. 256: 11923.
Schneider, W.J., Goldstein, J.W. and Brown, M.S. 1985. Purification of the LDL receptor. Methods Enzvmol. 109: 405.
Schneider, W.J., Brown, M.S. and Goldstein, J.L. 1983. Kinetic defects in the processing of low density lipoprotein receptor in fibroblasts from WHHL rabbits and a family with familial hypercholesterolemia. Mol. Biol. Med. 1L353.
Lehrman, M.A., Goldstein, J.L., Brown, M.S., Russell, D.W. and Schneider, W.J. 1985. Internalization-defective LDL receptors produced by genes with nonsense and frameshift mutations that truncate the cytoplasmic domain. Cell 41: 735.
Schneider, W.J. 1989. The low density lipoprotein receptor, Biochim. Biophvs. Acta 988: 303.
Goldstein J.L., Brown, M.S. and Stone, N.J. 1977. Genetics of LDL receptor. Evidence that mutations affecting binding and internalization are allelic. Cell 12: 629.
Davis, C.G., Lehrman, M.A., Russell, D.W., Anderson, R.G.W., Brown, M.S. and Goldstein J.L. 1986. The JD mutation in familial hypercholesterolemia. Amino acid substitution in cytoplasmic domain impedes internalization of LDL receptors. Cell 45: 15.
Lehrman, M.A., Schneider, W.J., Sudhoff, T., Brown, M.S., Goldstein, J.L. and Russell, D.W. 1985. Mutations in LDL receptor. ALU-ALU recombination deletes exon encoding transmembrane and cytoplasmic domains. Science 227: 140.
Miyake, Y., Tajima, S., Yamamura, T. and Yamamoto, A. 1981. Homozygous familial hypercholesterolemia mutant with a defect in internalization of low density lipoprotein. Proc. Natl. Acad. Sci. USA 78: 5151.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Schneider, W.J. (1991). Receptor-Mediated Low Density Lipoprotein Metabolism. In: Gotlieb, A.I., Langille, B.L., Fedoroff, S. (eds) Atherosclerosis. Altschul Symposia Series, vol 1. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3754-0_18
Download citation
DOI: https://doi.org/10.1007/978-1-4615-3754-0_18
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6672-0
Online ISBN: 978-1-4615-3754-0
eBook Packages: Springer Book Archive